nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—CYP3A4—Budesonide—ulcerative colitis	0.0818	0.178	CbGbCtD
Bexarotene—CYP2C9—Nicotine—ulcerative colitis	0.0612	0.133	CbGbCtD
Bexarotene—CYP2C9—Cholecalciferol—ulcerative colitis	0.0549	0.12	CbGbCtD
Bexarotene—CYP3A4—Methylprednisolone—ulcerative colitis	0.0365	0.0796	CbGbCtD
Bexarotene—CYP3A4—Nicotine—ulcerative colitis	0.0356	0.0776	CbGbCtD
Bexarotene—CYP3A4—Cholecalciferol—ulcerative colitis	0.0319	0.0696	CbGbCtD
Bexarotene—CYP3A4—Triamcinolone—ulcerative colitis	0.0277	0.0603	CbGbCtD
Bexarotene—CYP2C9—Dexamethasone—ulcerative colitis	0.0238	0.0518	CbGbCtD
Bexarotene—CYP3A4—Betamethasone—ulcerative colitis	0.0237	0.0518	CbGbCtD
Bexarotene—CYP3A4—Prednisolone—ulcerative colitis	0.0234	0.0511	CbGbCtD
Bexarotene—CYP3A4—Hydrocortisone—ulcerative colitis	0.0222	0.0484	CbGbCtD
Bexarotene—CYP3A4—Prednisone—ulcerative colitis	0.0221	0.0482	CbGbCtD
Bexarotene—CYP3A4—Dexamethasone—ulcerative colitis	0.0138	0.0301	CbGbCtD
Bexarotene—RXRA—Regulation of pyruvate dehydrogenase (PDH) complex—DLD—ulcerative colitis	0.00596	0.0346	CbGpPWpGaD
Bexarotene—RXRG—Nuclear Receptors—NR5A2—ulcerative colitis	0.00591	0.0344	CbGpPWpGaD
Bexarotene—RXRB—Vitamin D Metabolism—VDR—ulcerative colitis	0.00562	0.0327	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptors—NR5A2—ulcerative colitis	0.00555	0.0323	CbGpPWpGaD
Bexarotene—RXRG—a6b1 and a6b4 Integrin signaling—MST1—ulcerative colitis	0.00549	0.0319	CbGpPWpGaD
Bexarotene—RXRB—a6b1 and a6b4 Integrin signaling—MST1—ulcerative colitis	0.00516	0.03	CbGpPWpGaD
Bexarotene—RXRG—Nuclear Receptor transcription pathway—NR5A2—ulcerative colitis	0.00467	0.0272	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptor transcription pathway—NR5A2—ulcerative colitis	0.00439	0.0255	CbGpPWpGaD
Bexarotene—RXRA—Pyruvate metabolism—DLD—ulcerative colitis	0.00431	0.0251	CbGpPWpGaD
Bexarotene—RXRG—a6b1 and a6b4 Integrin signaling—LAMB1—ulcerative colitis	0.0038	0.0221	CbGpPWpGaD
Bexarotene—RXRB—a6b1 and a6b4 Integrin signaling—LAMB1—ulcerative colitis	0.00358	0.0208	CbGpPWpGaD
Bexarotene—RXRG—Nuclear Receptors—HNF4A—ulcerative colitis	0.0033	0.0192	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptors—HNF4A—ulcerative colitis	0.0031	0.0181	CbGpPWpGaD
Bexarotene—RXRA—Vitamin D Metabolism—VDR—ulcerative colitis	0.00293	0.017	CbGpPWpGaD
Bexarotene—RXRA—Nuclear Receptors—NR5A2—ulcerative colitis	0.00289	0.0168	CbGpPWpGaD
Bexarotene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—VDR—ulcerative colitis	0.00278	0.0162	CbGpPWpGaD
Bexarotene—RXRA—a6b1 and a6b4 Integrin signaling—MST1—ulcerative colitis	0.00269	0.0156	CbGpPWpGaD
Bexarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—VDR—ulcerative colitis	0.00262	0.0152	CbGpPWpGaD
Bexarotene—RXRG—Nuclear Receptor transcription pathway—HNF4A—ulcerative colitis	0.00261	0.0152	CbGpPWpGaD
Bexarotene—RXRA—Pyruvate metabolism and Citric Acid (TCA) cycle—DLD—ulcerative colitis	0.0026	0.0152	CbGpPWpGaD
Bexarotene—RXRG—Retinoic acid receptors-mediated signaling—VDR—ulcerative colitis	0.00248	0.0144	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptor transcription pathway—HNF4A—ulcerative colitis	0.00245	0.0143	CbGpPWpGaD
Bexarotene—RXRB—Retinoic acid receptors-mediated signaling—VDR—ulcerative colitis	0.00233	0.0136	CbGpPWpGaD
Bexarotene—RXRA—Nuclear Receptor transcription pathway—NR5A2—ulcerative colitis	0.00229	0.0133	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—SLC39A11—ulcerative colitis	0.00215	0.0125	CbGpPWpGaD
Bexarotene—RXRG—Nuclear Receptors—VDR—ulcerative colitis	0.00206	0.012	CbGpPWpGaD
Bexarotene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—PPARG—ulcerative colitis	0.00194	0.0113	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptors—VDR—ulcerative colitis	0.00193	0.0112	CbGpPWpGaD
Bexarotene—RXRA—a6b1 and a6b4 Integrin signaling—LAMB1—ulcerative colitis	0.00186	0.0108	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—MIF—ulcerative colitis	0.00184	0.0107	CbGpPWpGaD
Bexarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—PPARG—ulcerative colitis	0.00183	0.0106	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—ZFP90—ulcerative colitis	0.00176	0.0102	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—ZFP90—ulcerative colitis	0.00165	0.0096	CbGpPWpGaD
Bexarotene—RXRG—Nuclear Receptor transcription pathway—VDR—ulcerative colitis	0.00162	0.00945	CbGpPWpGaD
Bexarotene—RXRA—Nuclear Receptors—HNF4A—ulcerative colitis	0.00162	0.00941	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptor transcription pathway—VDR—ulcerative colitis	0.00153	0.00888	CbGpPWpGaD
Bexarotene—RXRG—Nuclear Receptors—PPARG—ulcerative colitis	0.00143	0.00834	CbGpPWpGaD
Bexarotene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—VDR—ulcerative colitis	0.00136	0.00794	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptors—PPARG—ulcerative colitis	0.00135	0.00784	CbGpPWpGaD
Bexarotene—RXRA—Nuclear Receptor transcription pathway—HNF4A—ulcerative colitis	0.00128	0.00743	CbGpPWpGaD
Bexarotene—RXRA—Recycling of bile acids and salts—ALB—ulcerative colitis	0.00126	0.00734	CbGpPWpGaD
Bexarotene—RXRA—Retinoic acid receptors-mediated signaling—VDR—ulcerative colitis	0.00122	0.00708	CbGpPWpGaD
Bexarotene—RXRG—a6b1 and a6b4 Integrin signaling—CDH1—ulcerative colitis	0.00119	0.00694	CbGpPWpGaD
Bexarotene—RXRA—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.00116	0.00674	CbGpPWpGaD
Bexarotene—RXRA—Transcriptional activation of mitochondrial biogenesis—CALM3—ulcerative colitis	0.00113	0.00659	CbGpPWpGaD
Bexarotene—RXRG—Nuclear Receptor transcription pathway—PPARG—ulcerative colitis	0.00113	0.00659	CbGpPWpGaD
Bexarotene—RXRB—a6b1 and a6b4 Integrin signaling—CDH1—ulcerative colitis	0.00112	0.00653	CbGpPWpGaD
Bexarotene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—ulcerative colitis	0.0011	0.00642	CbGpPWpGaD
Bexarotene—RXRA—Transcription factor regulation in adipogenesis—PPARG—ulcerative colitis	0.00109	0.00632	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptor transcription pathway—PPARG—ulcerative colitis	0.00106	0.00619	CbGpPWpGaD
Bexarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—ulcerative colitis	0.00104	0.00604	CbGpPWpGaD
Bexarotene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TNF—ulcerative colitis	0.00103	0.006	CbGpPWpGaD
Bexarotene—RXRA—The citric acid (TCA) cycle and respiratory electron transport—DLD—ulcerative colitis	0.00101	0.00588	CbGpPWpGaD
Bexarotene—RXRA—Nuclear Receptors—VDR—ulcerative colitis	0.00101	0.00586	CbGpPWpGaD
Bexarotene—RXRA—Mitochondrial biogenesis—CALM3—ulcerative colitis	0.00098	0.0057	CbGpPWpGaD
Bexarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—ulcerative colitis	0.000969	0.00564	CbGpPWpGaD
Bexarotene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—ulcerative colitis	0.000951	0.00553	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—MIF—ulcerative colitis	0.000903	0.00525	CbGpPWpGaD
Bexarotene—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.000864	0.00503	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—ZFP90—ulcerative colitis	0.00086	0.00501	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	0.000846	0.00492	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—ZFP90—ulcerative colitis	0.000846	0.00492	CbGpPWpGaD
Bexarotene—RXRA—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000811	0.00472	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—NR5A2—ulcerative colitis	0.000806	0.00469	CbGpPWpGaD
Bexarotene—RXRA—Nuclear Receptor transcription pathway—VDR—ulcerative colitis	0.000796	0.00463	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—ZFP90—ulcerative colitis	0.000795	0.00462	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—NR5A2—ulcerative colitis	0.000758	0.00441	CbGpPWpGaD
Bexarotene—RXRA—Nuclear Receptors—PPARG—ulcerative colitis	0.000702	0.00408	CbGpPWpGaD
Bexarotene—RXRA—Bile acid and bile salt metabolism—ALB—ulcerative colitis	0.000659	0.00384	CbGpPWpGaD
Bexarotene—RXRA—a6b1 and a6b4 Integrin signaling—CDH1—ulcerative colitis	0.000585	0.0034	CbGpPWpGaD
Bexarotene—RXRA—Transcription factor regulation in adipogenesis—TNF—ulcerative colitis	0.000577	0.00336	CbGpPWpGaD
Bexarotene—RXRA—Nuclear Receptor transcription pathway—PPARG—ulcerative colitis	0.000555	0.00323	CbGpPWpGaD
Bexarotene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—ulcerative colitis	0.000541	0.00315	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—PPARG—ulcerative colitis	0.000536	0.00312	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000521	0.00303	CbGpPWpGaD
Bexarotene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—ulcerative colitis	0.000505	0.00294	CbGpPWpGaD
Bexarotene—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	0.000473	0.00275	CbGpPWpGaD
Bexarotene—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.000472	0.00275	CbGpPWpGaD
Bexarotene—RXRA—Transcription factor regulation in adipogenesis—IL6—ulcerative colitis	0.000466	0.00271	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—HNF4A—ulcerative colitis	0.000451	0.00262	CbGpPWpGaD
Bexarotene—RXRA—Organelle biogenesis and maintenance—CALM3—ulcerative colitis	0.000445	0.00259	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	0.000444	0.00259	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—MAML2—ulcerative colitis	0.000439	0.00255	CbGpPWpGaD
Bexarotene—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000432	0.00251	CbGpPWpGaD
Bexarotene—CYP2C9—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000432	0.00251	CbGpPWpGaD
Bexarotene—RXRA—Biological oxidations—PTGS1—ulcerative colitis	0.000431	0.00251	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—HNF4A—ulcerative colitis	0.000424	0.00246	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—ZFP90—ulcerative colitis	0.000414	0.00241	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—MAML2—ulcerative colitis	0.000413	0.0024	CbGpPWpGaD
Bexarotene—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000412	0.0024	CbGpPWpGaD
Bexarotene—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000411	0.00239	CbGpPWpGaD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—PPARG—ulcerative colitis	0.000399	0.00232	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—NR5A2—ulcerative colitis	0.000395	0.0023	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—NR5A2—ulcerative colitis	0.000388	0.00226	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—ARPC2—ulcerative colitis	0.000383	0.00223	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—NR5A2—ulcerative colitis	0.000372	0.00216	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—NR5A2—ulcerative colitis	0.000365	0.00212	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—STAT3—ulcerative colitis	0.000329	0.00191	CbGpPWpGaD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—RELA—ulcerative colitis	0.000323	0.00188	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.000307	0.00179	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	0.000307	0.00179	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—TGFB1—ulcerative colitis	0.000305	0.00177	CbGpPWpGaD
Bexarotene—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000303	0.00176	CbGpPWpGaD
Bexarotene—RXRA—PPARA activates gene expression—PPARG—ulcerative colitis	0.0003	0.00175	CbGpPWpGaD
Bexarotene—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—ulcerative colitis	0.000294	0.00171	CbGpPWpGaD
Bexarotene—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000287	0.00167	CbGpPWpGaD
Bexarotene—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000285	0.00166	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—TNF—ulcerative colitis	0.000284	0.00165	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—VDR—ulcerative colitis	0.000281	0.00163	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	0.000277	0.00161	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—LAMB1—ulcerative colitis	0.000274	0.00159	CbGpPWpGaD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—NFKB1—ulcerative colitis	0.000272	0.00159	CbGpPWpGaD
Bexarotene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000272	0.00158	CbGpPWpGaD
Bexarotene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000271	0.00158	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—VDR—ulcerative colitis	0.000264	0.00153	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—PPARG—ulcerative colitis	0.000262	0.00153	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TCF4—ulcerative colitis	0.00024	0.00139	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—IL6—ulcerative colitis	0.00023	0.00134	CbGpPWpGaD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—TGFB1—ulcerative colitis	0.000227	0.00132	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—HNF4A—ulcerative colitis	0.000221	0.00128	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—HNF4A—ulcerative colitis	0.000217	0.00126	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—MAML2—ulcerative colitis	0.000215	0.00125	CbGpPWpGaD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—ulcerative colitis	0.000212	0.00123	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—MAML2—ulcerative colitis	0.000211	0.00123	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—HNF4A—ulcerative colitis	0.000208	0.00121	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—HNF4A—ulcerative colitis	0.000204	0.00119	CbGpPWpGaD
Bexarotene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—ulcerative colitis	0.000202	0.00118	CbGpPWpGaD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.0002	0.00116	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—MAML2—ulcerative colitis	0.000199	0.00116	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—PPARG—ulcerative colitis	0.000196	0.00114	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	0.000191	0.00111	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—NR5A2—ulcerative colitis	0.00019	0.00111	CbGpPWpGaD
Bexarotene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000189	0.0011	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—PPARG—ulcerative colitis	0.000184	0.00107	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CHP1—ulcerative colitis	0.000177	0.00103	CbGpPWpGaD
Bexarotene—Syncope—Triamcinolone—ulcerative colitis	0.000174	0.000471	CcSEcCtD
Bexarotene—Vertigo—Methylprednisolone—ulcerative colitis	0.000174	0.000471	CcSEcCtD
Bexarotene—Syncope—Methylprednisolone—ulcerative colitis	0.000174	0.00047	CcSEcCtD
Bexarotene—Discomfort—Hydrocortisone—ulcerative colitis	0.000173	0.00047	CcSEcCtD
Bexarotene—Connective tissue disorder—Prednisone—ulcerative colitis	0.000173	0.000469	CcSEcCtD
Bexarotene—Nausea—Budesonide—ulcerative colitis	0.000173	0.000468	CcSEcCtD
Bexarotene—Oedema—Prednisolone—ulcerative colitis	0.000172	0.000467	CcSEcCtD
Bexarotene—Dizziness—Azathioprine—ulcerative colitis	0.000172	0.000465	CcSEcCtD
Bexarotene—Loss of consciousness—Triamcinolone—ulcerative colitis	0.000171	0.000462	CcSEcCtD
Bexarotene—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.00017	0.000461	CcSEcCtD
Bexarotene—Asthenia—Mesalazine—ulcerative colitis	0.00017	0.00046	CcSEcCtD
Bexarotene—Shock—Prednisolone—ulcerative colitis	0.00017	0.000459	CcSEcCtD
Bexarotene—Cough—Triamcinolone—ulcerative colitis	0.000169	0.000459	CcSEcCtD
Bexarotene—Oedema—Hydrocortisone—ulcerative colitis	0.000168	0.000456	CcSEcCtD
Bexarotene—Tachycardia—Prednisolone—ulcerative colitis	0.000168	0.000455	CcSEcCtD
Bexarotene—Hypertension—Triamcinolone—ulcerative colitis	0.000168	0.000454	CcSEcCtD
Bexarotene—Pruritus—Mesalazine—ulcerative colitis	0.000167	0.000453	CcSEcCtD
Bexarotene—Hypertension—Methylprednisolone—ulcerative colitis	0.000167	0.000453	CcSEcCtD
Bexarotene—Infection—Hydrocortisone—ulcerative colitis	0.000167	0.000453	CcSEcCtD
Bexarotene—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000167	0.000451	CcSEcCtD
Bexarotene—CYP2C9—Arachidonic acid metabolism—PTGS2—ulcerative colitis	0.000166	0.000963	CbGpPWpGaD
Bexarotene—Shock—Hydrocortisone—ulcerative colitis	0.000166	0.000448	CcSEcCtD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	0.000165	0.000962	CbGpPWpGaD
Bexarotene—Myalgia—Triamcinolone—ulcerative colitis	0.000165	0.000448	CcSEcCtD
Bexarotene—Vomiting—Azathioprine—ulcerative colitis	0.000165	0.000447	CcSEcCtD
Bexarotene—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000165	0.000447	CcSEcCtD
Bexarotene—Myalgia—Methylprednisolone—ulcerative colitis	0.000165	0.000447	CcSEcCtD
Bexarotene—Arthralgia—Methylprednisolone—ulcerative colitis	0.000165	0.000447	CcSEcCtD
Bexarotene—Eye disorder—Prednisone—ulcerative colitis	0.000165	0.000446	CcSEcCtD
Bexarotene—Anxiety—Methylprednisolone—ulcerative colitis	0.000164	0.000445	CcSEcCtD
Bexarotene—Tachycardia—Hydrocortisone—ulcerative colitis	0.000164	0.000445	CcSEcCtD
Bexarotene—Rash—Azathioprine—ulcerative colitis	0.000164	0.000444	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000164	0.000444	CcSEcCtD
Bexarotene—Dermatitis—Azathioprine—ulcerative colitis	0.000164	0.000443	CcSEcCtD
Bexarotene—Skin disorder—Hydrocortisone—ulcerative colitis	0.000163	0.000443	CcSEcCtD
Bexarotene—Ill-defined disorder—Betamethasone—ulcerative colitis	0.000163	0.000443	CcSEcCtD
Bexarotene—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.000163	0.000443	CcSEcCtD
Bexarotene—Discomfort—Triamcinolone—ulcerative colitis	0.000163	0.000442	CcSEcCtD
Bexarotene—Discomfort—Methylprednisolone—ulcerative colitis	0.000163	0.000441	CcSEcCtD
Bexarotene—Headache—Azathioprine—ulcerative colitis	0.000163	0.000441	CcSEcCtD
Bexarotene—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000163	0.000441	CcSEcCtD
Bexarotene—Diarrhoea—Mesalazine—ulcerative colitis	0.000162	0.000438	CcSEcCtD
Bexarotene—Dry mouth—Triamcinolone—ulcerative colitis	0.000162	0.000438	CcSEcCtD
Bexarotene—RXRA—Adipogenesis—STAT3—ulcerative colitis	0.000161	0.000937	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—PTGS1—ulcerative colitis	0.000161	0.000935	CbGpPWpGaD
Bexarotene—Anorexia—Hydrocortisone—ulcerative colitis	0.00016	0.000434	CcSEcCtD
Bexarotene—Angiopathy—Prednisone—ulcerative colitis	0.00016	0.000433	CcSEcCtD
Bexarotene—Confusional state—Methylprednisolone—ulcerative colitis	0.000159	0.000432	CcSEcCtD
Bexarotene—Malaise—Dexamethasone—ulcerative colitis	0.000159	0.00043	CcSEcCtD
Bexarotene—Malaise—Betamethasone—ulcerative colitis	0.000159	0.00043	CcSEcCtD
Bexarotene—Oedema—Triamcinolone—ulcerative colitis	0.000158	0.000429	CcSEcCtD
Bexarotene—Vertigo—Dexamethasone—ulcerative colitis	0.000158	0.000429	CcSEcCtD
Bexarotene—Vertigo—Betamethasone—ulcerative colitis	0.000158	0.000429	CcSEcCtD
Bexarotene—Syncope—Dexamethasone—ulcerative colitis	0.000158	0.000428	CcSEcCtD
Bexarotene—Syncope—Betamethasone—ulcerative colitis	0.000158	0.000428	CcSEcCtD
Bexarotene—Arrhythmia—Prednisone—ulcerative colitis	0.000157	0.000426	CcSEcCtD
Bexarotene—Infection—Triamcinolone—ulcerative colitis	0.000157	0.000426	CcSEcCtD
Bexarotene—Infection—Methylprednisolone—ulcerative colitis	0.000157	0.000425	CcSEcCtD
Bexarotene—Dizziness—Mesalazine—ulcerative colitis	0.000156	0.000424	CcSEcCtD
Bexarotene—Shock—Triamcinolone—ulcerative colitis	0.000156	0.000422	CcSEcCtD
Bexarotene—Insomnia—Prednisolone—ulcerative colitis	0.000156	0.000422	CcSEcCtD
Bexarotene—Alopecia—Prednisone—ulcerative colitis	0.000156	0.000422	CcSEcCtD
Bexarotene—Shock—Methylprednisolone—ulcerative colitis	0.000156	0.000421	CcSEcCtD
Bexarotene—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000155	0.00042	CcSEcCtD
Bexarotene—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000155	0.000419	CcSEcCtD
Bexarotene—Loss of consciousness—Betamethasone—ulcerative colitis	0.000155	0.000419	CcSEcCtD
Bexarotene—Paraesthesia—Prednisolone—ulcerative colitis	0.000155	0.000419	CcSEcCtD
Bexarotene—Tachycardia—Triamcinolone—ulcerative colitis	0.000155	0.000419	CcSEcCtD
Bexarotene—Nausea—Azathioprine—ulcerative colitis	0.000154	0.000418	CcSEcCtD
Bexarotene—Tachycardia—Methylprednisolone—ulcerative colitis	0.000154	0.000418	CcSEcCtD
Bexarotene—Skin disorder—Methylprednisolone—ulcerative colitis	0.000154	0.000416	CcSEcCtD
Bexarotene—Erythema—Prednisone—ulcerative colitis	0.000153	0.000415	CcSEcCtD
Bexarotene—Malnutrition—Prednisone—ulcerative colitis	0.000153	0.000415	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000153	0.000415	CcSEcCtD
Bexarotene—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000153	0.000415	CcSEcCtD
Bexarotene—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000153	0.000414	CcSEcCtD
Bexarotene—RXRA—Metabolism—DLD—ulcerative colitis	0.000152	0.000886	CbGpPWpGaD
Bexarotene—Insomnia—Hydrocortisone—ulcerative colitis	0.000152	0.000412	CcSEcCtD
Bexarotene—Hypertension—Betamethasone—ulcerative colitis	0.000152	0.000412	CcSEcCtD
Bexarotene—Hypertension—Dexamethasone—ulcerative colitis	0.000152	0.000412	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	0.000152	0.000883	CbGpPWpGaD
Bexarotene—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000151	0.000409	CcSEcCtD
Bexarotene—Vomiting—Mesalazine—ulcerative colitis	0.00015	0.000407	CcSEcCtD
Bexarotene—Myalgia—Dexamethasone—ulcerative colitis	0.00015	0.000406	CcSEcCtD
Bexarotene—Myalgia—Betamethasone—ulcerative colitis	0.00015	0.000406	CcSEcCtD
Bexarotene—Anxiety—Betamethasone—ulcerative colitis	0.000149	0.000405	CcSEcCtD
Bexarotene—Anxiety—Dexamethasone—ulcerative colitis	0.000149	0.000405	CcSEcCtD
Bexarotene—RXRA—Adipogenesis—TGFB1—ulcerative colitis	0.000149	0.000868	CbGpPWpGaD
Bexarotene—Rash—Mesalazine—ulcerative colitis	0.000149	0.000404	CcSEcCtD
Bexarotene—Dermatitis—Mesalazine—ulcerative colitis	0.000149	0.000404	CcSEcCtD
Bexarotene—Headache—Mesalazine—ulcerative colitis	0.000148	0.000401	CcSEcCtD
Bexarotene—Discomfort—Dexamethasone—ulcerative colitis	0.000148	0.000401	CcSEcCtD
Bexarotene—Discomfort—Betamethasone—ulcerative colitis	0.000148	0.000401	CcSEcCtD
Bexarotene—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000148	0.000401	CcSEcCtD
Bexarotene—Pain—Prednisolone—ulcerative colitis	0.000147	0.000399	CcSEcCtD
Bexarotene—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000146	0.000396	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000145	0.000393	CcSEcCtD
Bexarotene—Fatigue—Hydrocortisone—ulcerative colitis	0.000145	0.000393	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000144	0.000391	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000144	0.00039	CcSEcCtD
Bexarotene—Pain—Hydrocortisone—ulcerative colitis	0.000144	0.00039	CcSEcCtD
Bexarotene—Oedema—Dexamethasone—ulcerative colitis	0.000144	0.000389	CcSEcCtD
Bexarotene—Oedema—Betamethasone—ulcerative colitis	0.000144	0.000389	CcSEcCtD
Bexarotene—Insomnia—Triamcinolone—ulcerative colitis	0.000143	0.000388	CcSEcCtD
Bexarotene—Insomnia—Methylprednisolone—ulcerative colitis	0.000143	0.000387	CcSEcCtD
Bexarotene—Infection—Dexamethasone—ulcerative colitis	0.000143	0.000387	CcSEcCtD
Bexarotene—Infection—Betamethasone—ulcerative colitis	0.000143	0.000387	CcSEcCtD
Bexarotene—Ill-defined disorder—Prednisone—ulcerative colitis	0.000142	0.000385	CcSEcCtD
Bexarotene—Paraesthesia—Triamcinolone—ulcerative colitis	0.000142	0.000385	CcSEcCtD
Bexarotene—Feeling abnormal—Prednisolone—ulcerative colitis	0.000142	0.000384	CcSEcCtD
Bexarotene—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000142	0.000384	CcSEcCtD
Bexarotene—Anaemia—Prednisone—ulcerative colitis	0.000142	0.000384	CcSEcCtD
Bexarotene—Shock—Dexamethasone—ulcerative colitis	0.000141	0.000383	CcSEcCtD
Bexarotene—Shock—Betamethasone—ulcerative colitis	0.000141	0.000383	CcSEcCtD
Bexarotene—Dyspnoea—Triamcinolone—ulcerative colitis	0.000141	0.000383	CcSEcCtD
Bexarotene—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000141	0.000382	CcSEcCtD
Bexarotene—Nervous system disorder—Betamethasone—ulcerative colitis	0.000141	0.000382	CcSEcCtD
Bexarotene—Agitation—Prednisone—ulcerative colitis	0.000141	0.000382	CcSEcCtD
Bexarotene—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000141	0.000381	CcSEcCtD
Bexarotene—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000141	0.000381	CcSEcCtD
Bexarotene—Nausea—Mesalazine—ulcerative colitis	0.000141	0.000381	CcSEcCtD
Bexarotene—Tachycardia—Dexamethasone—ulcerative colitis	0.00014	0.00038	CcSEcCtD
Bexarotene—Tachycardia—Betamethasone—ulcerative colitis	0.00014	0.00038	CcSEcCtD
Bexarotene—Dyspepsia—Triamcinolone—ulcerative colitis	0.000139	0.000378	CcSEcCtD
Bexarotene—RXRA—Adipogenesis—TNF—ulcerative colitis	0.000139	0.000811	CbGpPWpGaD
Bexarotene—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000139	0.000377	CcSEcCtD
Bexarotene—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.000139	0.000376	CcSEcCtD
Bexarotene—Hyperhidrosis—Betamethasone—ulcerative colitis	0.000139	0.000376	CcSEcCtD
Bexarotene—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.000139	0.000375	CcSEcCtD
Bexarotene—Malaise—Prednisone—ulcerative colitis	0.000138	0.000375	CcSEcCtD
Bexarotene—Vertigo—Prednisone—ulcerative colitis	0.000138	0.000373	CcSEcCtD
Bexarotene—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000138	0.000373	CcSEcCtD
Bexarotene—Syncope—Prednisone—ulcerative colitis	0.000138	0.000373	CcSEcCtD
Bexarotene—RXRA—Generic Transcription Pathway—VDR—ulcerative colitis	0.000137	0.0008	CbGpPWpGaD
Bexarotene—Anorexia—Dexamethasone—ulcerative colitis	0.000137	0.000371	CcSEcCtD
Bexarotene—Anorexia—Betamethasone—ulcerative colitis	0.000137	0.000371	CcSEcCtD
Bexarotene—Fatigue—Triamcinolone—ulcerative colitis	0.000137	0.00037	CcSEcCtD
Bexarotene—Fatigue—Methylprednisolone—ulcerative colitis	0.000136	0.000369	CcSEcCtD
Bexarotene—RXRA—NRF2 pathway—TGFB1—ulcerative colitis	0.000136	0.000791	CbGpPWpGaD
Bexarotene—Pain—Triamcinolone—ulcerative colitis	0.000136	0.000367	CcSEcCtD
Bexarotene—RXRG—Gene Expression—VDR—ulcerative colitis	0.000135	0.000786	CbGpPWpGaD
Bexarotene—Loss of consciousness—Prednisone—ulcerative colitis	0.000135	0.000365	CcSEcCtD
Bexarotene—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000133	0.00036	CcSEcCtD
Bexarotene—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000133	0.00036	CcSEcCtD
Bexarotene—Hypertension—Prednisone—ulcerative colitis	0.000132	0.000359	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	0.000132	0.000766	CbGpPWpGaD
Bexarotene—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000131	0.000355	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000131	0.000355	CcSEcCtD
Bexarotene—Myalgia—Prednisone—ulcerative colitis	0.000131	0.000354	CcSEcCtD
Bexarotene—Arthralgia—Prednisone—ulcerative colitis	0.000131	0.000354	CcSEcCtD
Bexarotene—Feeling abnormal—Triamcinolone—ulcerative colitis	0.000131	0.000354	CcSEcCtD
Bexarotene—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.00013	0.000353	CcSEcCtD
Bexarotene—Anxiety—Prednisone—ulcerative colitis	0.00013	0.000352	CcSEcCtD
Bexarotene—Insomnia—Dexamethasone—ulcerative colitis	0.00013	0.000352	CcSEcCtD
Bexarotene—Insomnia—Betamethasone—ulcerative colitis	0.00013	0.000352	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.00013	0.000351	CcSEcCtD
Bexarotene—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000129	0.00035	CcSEcCtD
Bexarotene—Paraesthesia—Betamethasone—ulcerative colitis	0.000129	0.00035	CcSEcCtD
Bexarotene—Paraesthesia—Dexamethasone—ulcerative colitis	0.000129	0.00035	CcSEcCtD
Bexarotene—Discomfort—Prednisone—ulcerative colitis	0.000129	0.000349	CcSEcCtD
Bexarotene—RXRB—Gene Expression—VDR—ulcerative colitis	0.000127	0.000739	CbGpPWpGaD
Bexarotene—Hypersensitivity—Prednisolone—ulcerative colitis	0.000127	0.000344	CcSEcCtD
Bexarotene—Dyspepsia—Betamethasone—ulcerative colitis	0.000127	0.000343	CcSEcCtD
Bexarotene—Dyspepsia—Dexamethasone—ulcerative colitis	0.000127	0.000343	CcSEcCtD
Bexarotene—Body temperature increased—Triamcinolone—ulcerative colitis	0.000125	0.000339	CcSEcCtD
Bexarotene—Oedema—Prednisone—ulcerative colitis	0.000125	0.000339	CcSEcCtD
Bexarotene—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000125	0.000338	CcSEcCtD
Bexarotene—Decreased appetite—Dexamethasone—ulcerative colitis	0.000125	0.000338	CcSEcCtD
Bexarotene—Decreased appetite—Betamethasone—ulcerative colitis	0.000125	0.000338	CcSEcCtD
Bexarotene—Infection—Prednisone—ulcerative colitis	0.000124	0.000337	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000124	0.000336	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000124	0.000336	CcSEcCtD
Bexarotene—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000124	0.000336	CcSEcCtD
Bexarotene—Fatigue—Betamethasone—ulcerative colitis	0.000124	0.000336	CcSEcCtD
Bexarotene—Fatigue—Dexamethasone—ulcerative colitis	0.000124	0.000336	CcSEcCtD
Bexarotene—Shock—Prednisone—ulcerative colitis	0.000123	0.000334	CcSEcCtD
Bexarotene—Pain—Betamethasone—ulcerative colitis	0.000123	0.000333	CcSEcCtD
Bexarotene—Pain—Dexamethasone—ulcerative colitis	0.000123	0.000333	CcSEcCtD
Bexarotene—Nervous system disorder—Prednisone—ulcerative colitis	0.000123	0.000332	CcSEcCtD
Bexarotene—Tachycardia—Prednisone—ulcerative colitis	0.000122	0.000331	CcSEcCtD
Bexarotene—Skin disorder—Prednisone—ulcerative colitis	0.000122	0.000329	CcSEcCtD
Bexarotene—Hyperhidrosis—Prednisone—ulcerative colitis	0.000121	0.000328	CcSEcCtD
Bexarotene—Asthenia—Hydrocortisone—ulcerative colitis	0.000121	0.000327	CcSEcCtD
Bexarotene—Anorexia—Prednisone—ulcerative colitis	0.000119	0.000323	CcSEcCtD
Bexarotene—Pruritus—Hydrocortisone—ulcerative colitis	0.000119	0.000322	CcSEcCtD
Bexarotene—Feeling abnormal—Betamethasone—ulcerative colitis	0.000118	0.000321	CcSEcCtD
Bexarotene—Feeling abnormal—Dexamethasone—ulcerative colitis	0.000118	0.000321	CcSEcCtD
Bexarotene—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000118	0.000318	CcSEcCtD
Bexarotene—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000118	0.000318	CcSEcCtD
Bexarotene—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000117	0.000316	CcSEcCtD
Bexarotene—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000116	0.000315	CcSEcCtD
Bexarotene—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000115	0.000312	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.000114	0.000309	CcSEcCtD
Bexarotene—Dizziness—Prednisolone—ulcerative colitis	0.000114	0.000309	CcSEcCtD
Bexarotene—Asthenia—Triamcinolone—ulcerative colitis	0.000114	0.000308	CcSEcCtD
Bexarotene—Body temperature increased—Dexamethasone—ulcerative colitis	0.000114	0.000308	CcSEcCtD
Bexarotene—Abdominal pain—Betamethasone—ulcerative colitis	0.000114	0.000308	CcSEcCtD
Bexarotene—Body temperature increased—Betamethasone—ulcerative colitis	0.000114	0.000308	CcSEcCtD
Bexarotene—Abdominal pain—Dexamethasone—ulcerative colitis	0.000114	0.000308	CcSEcCtD
Bexarotene—Asthenia—Methylprednisolone—ulcerative colitis	0.000113	0.000307	CcSEcCtD
Bexarotene—Insomnia—Prednisone—ulcerative colitis	0.000113	0.000307	CcSEcCtD
Bexarotene—RXRA—Adipogenesis—IL6—ulcerative colitis	0.000112	0.000654	CbGpPWpGaD
Bexarotene—Paraesthesia—Prednisone—ulcerative colitis	0.000112	0.000304	CcSEcCtD
Bexarotene—Pruritus—Triamcinolone—ulcerative colitis	0.000112	0.000304	CcSEcCtD
Bexarotene—Pruritus—Methylprednisolone—ulcerative colitis	0.000112	0.000303	CcSEcCtD
Bexarotene—Dizziness—Hydrocortisone—ulcerative colitis	0.000111	0.000301	CcSEcCtD
Bexarotene—Dyspepsia—Prednisone—ulcerative colitis	0.00011	0.000298	CcSEcCtD
Bexarotene—RXRA—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	0.00011	0.000641	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	0.00011	0.000638	CbGpPWpGaD
Bexarotene—Decreased appetite—Prednisone—ulcerative colitis	0.000109	0.000295	CcSEcCtD
Bexarotene—Rash—Prednisolone—ulcerative colitis	0.000109	0.000294	CcSEcCtD
Bexarotene—Dermatitis—Prednisolone—ulcerative colitis	0.000109	0.000294	CcSEcCtD
Bexarotene—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000108	0.000293	CcSEcCtD
Bexarotene—Fatigue—Prednisone—ulcerative colitis	0.000108	0.000292	CcSEcCtD
Bexarotene—Headache—Prednisolone—ulcerative colitis	0.000108	0.000292	CcSEcCtD
Bexarotene—Constipation—Prednisone—ulcerative colitis	0.000107	0.00029	CcSEcCtD
Bexarotene—Vomiting—Hydrocortisone—ulcerative colitis	0.000107	0.00029	CcSEcCtD
Bexarotene—RXRA—Gene Expression—HNF4A—ulcerative colitis	0.000106	0.000618	CbGpPWpGaD
Bexarotene—Rash—Hydrocortisone—ulcerative colitis	0.000106	0.000287	CcSEcCtD
Bexarotene—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	0.000106	0.000617	CbGpPWpGaD
Bexarotene—Dermatitis—Hydrocortisone—ulcerative colitis	0.000106	0.000287	CcSEcCtD
Bexarotene—Headache—Hydrocortisone—ulcerative colitis	0.000105	0.000285	CcSEcCtD
Bexarotene—Dizziness—Triamcinolone—ulcerative colitis	0.000105	0.000284	CcSEcCtD
Bexarotene—Dizziness—Methylprednisolone—ulcerative colitis	0.000105	0.000283	CcSEcCtD
Bexarotene—RXRA—Gene Expression—MAML2—ulcerative colitis	0.000104	0.000603	CbGpPWpGaD
Bexarotene—Feeling abnormal—Prednisone—ulcerative colitis	0.000103	0.000279	CcSEcCtD
Bexarotene—Asthenia—Betamethasone—ulcerative colitis	0.000103	0.000279	CcSEcCtD
Bexarotene—Asthenia—Dexamethasone—ulcerative colitis	0.000103	0.000279	CcSEcCtD
Bexarotene—RXRA—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	0.000103	0.000598	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	0.000102	0.000596	CbGpPWpGaD
Bexarotene—Gastrointestinal pain—Prednisone—ulcerative colitis	0.000102	0.000277	CcSEcCtD
Bexarotene—Nausea—Prednisolone—ulcerative colitis	0.000102	0.000277	CcSEcCtD
Bexarotene—Pruritus—Betamethasone—ulcerative colitis	0.000102	0.000275	CcSEcCtD
Bexarotene—Pruritus—Dexamethasone—ulcerative colitis	0.000102	0.000275	CcSEcCtD
Bexarotene—Vomiting—Triamcinolone—ulcerative colitis	0.000101	0.000273	CcSEcCtD
Bexarotene—Vomiting—Methylprednisolone—ulcerative colitis	0.000101	0.000272	CcSEcCtD
Bexarotene—Nausea—Hydrocortisone—ulcerative colitis	0.0001	0.000271	CcSEcCtD
Bexarotene—Rash—Triamcinolone—ulcerative colitis	9.99e-05	0.000271	CcSEcCtD
Bexarotene—Dermatitis—Triamcinolone—ulcerative colitis	9.98e-05	0.00027	CcSEcCtD
Bexarotene—Rash—Methylprednisolone—ulcerative colitis	9.97e-05	0.00027	CcSEcCtD
Bexarotene—Dermatitis—Methylprednisolone—ulcerative colitis	9.96e-05	0.00027	CcSEcCtD
Bexarotene—Headache—Triamcinolone—ulcerative colitis	9.93e-05	0.000269	CcSEcCtD
Bexarotene—Headache—Methylprednisolone—ulcerative colitis	9.9e-05	0.000268	CcSEcCtD
Bexarotene—Abdominal pain—Prednisone—ulcerative colitis	9.9e-05	0.000268	CcSEcCtD
Bexarotene—Body temperature increased—Prednisone—ulcerative colitis	9.9e-05	0.000268	CcSEcCtD
Bexarotene—Diarrhoea—Betamethasone—ulcerative colitis	9.84e-05	0.000266	CcSEcCtD
Bexarotene—Diarrhoea—Dexamethasone—ulcerative colitis	9.84e-05	0.000266	CcSEcCtD
Bexarotene—RXRA—Generic Transcription Pathway—PPARG—ulcerative colitis	9.58e-05	0.000558	CbGpPWpGaD
Bexarotene—Dizziness—Betamethasone—ulcerative colitis	9.51e-05	0.000257	CcSEcCtD
Bexarotene—Dizziness—Dexamethasone—ulcerative colitis	9.51e-05	0.000257	CcSEcCtD
Bexarotene—RXRG—Gene Expression—PPARG—ulcerative colitis	9.42e-05	0.000548	CbGpPWpGaD
Bexarotene—Nausea—Triamcinolone—ulcerative colitis	9.41e-05	0.000255	CcSEcCtD
Bexarotene—Nausea—Methylprednisolone—ulcerative colitis	9.39e-05	0.000254	CcSEcCtD
Bexarotene—Hypersensitivity—Prednisone—ulcerative colitis	9.22e-05	0.00025	CcSEcCtD
Bexarotene—Vomiting—Betamethasone—ulcerative colitis	9.14e-05	0.000248	CcSEcCtD
Bexarotene—Vomiting—Dexamethasone—ulcerative colitis	9.14e-05	0.000248	CcSEcCtD
Bexarotene—Rash—Betamethasone—ulcerative colitis	9.07e-05	0.000245	CcSEcCtD
Bexarotene—Rash—Dexamethasone—ulcerative colitis	9.07e-05	0.000245	CcSEcCtD
Bexarotene—Dermatitis—Dexamethasone—ulcerative colitis	9.06e-05	0.000245	CcSEcCtD
Bexarotene—Dermatitis—Betamethasone—ulcerative colitis	9.06e-05	0.000245	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	9.03e-05	0.000526	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—PPARG—ulcerative colitis	9.02e-05	0.000525	CbGpPWpGaD
Bexarotene—Headache—Dexamethasone—ulcerative colitis	9.01e-05	0.000244	CcSEcCtD
Bexarotene—Headache—Betamethasone—ulcerative colitis	9.01e-05	0.000244	CcSEcCtD
Bexarotene—Asthenia—Prednisone—ulcerative colitis	8.98e-05	0.000243	CcSEcCtD
Bexarotene—Pruritus—Prednisone—ulcerative colitis	8.86e-05	0.00024	CcSEcCtD
Bexarotene—RXRB—Gene Expression—PPARG—ulcerative colitis	8.85e-05	0.000515	CbGpPWpGaD
Bexarotene—Diarrhoea—Prednisone—ulcerative colitis	8.57e-05	0.000232	CcSEcCtD
Bexarotene—Nausea—Betamethasone—ulcerative colitis	8.54e-05	0.000231	CcSEcCtD
Bexarotene—Nausea—Dexamethasone—ulcerative colitis	8.54e-05	0.000231	CcSEcCtD
Bexarotene—Dizziness—Prednisone—ulcerative colitis	8.28e-05	0.000224	CcSEcCtD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	8.06e-05	0.000469	CbGpPWpGaD
Bexarotene—Vomiting—Prednisone—ulcerative colitis	7.96e-05	0.000216	CcSEcCtD
Bexarotene—Rash—Prednisone—ulcerative colitis	7.89e-05	0.000214	CcSEcCtD
Bexarotene—Dermatitis—Prednisone—ulcerative colitis	7.89e-05	0.000214	CcSEcCtD
Bexarotene—Headache—Prednisone—ulcerative colitis	7.84e-05	0.000212	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—JAK2—ulcerative colitis	7.54e-05	0.000439	CbGpPWpGaD
Bexarotene—Nausea—Prednisone—ulcerative colitis	7.44e-05	0.000201	CcSEcCtD
Bexarotene—RXRA—Metabolism—PTGS1—ulcerative colitis	7.37e-05	0.000428	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—RELA—ulcerative colitis	7.3e-05	0.000425	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	7.24e-05	0.000421	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—ALB—ulcerative colitis	6.89e-05	0.000401	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CALM3—ulcerative colitis	6.63e-05	0.000386	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—VDR—ulcerative colitis	6.62e-05	0.000385	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CHP1—ulcerative colitis	6.59e-05	0.000383	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	6.34e-05	0.000369	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MMP9—ulcerative colitis	6.23e-05	0.000362	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	6.17e-05	0.000359	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—NFKB1—ulcerative colitis	6.16e-05	0.000358	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—DLD—ulcerative colitis	5.69e-05	0.000331	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—STAT3—ulcerative colitis	5.54e-05	0.000322	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ABCB1—ulcerative colitis	5.16e-05	0.0003	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TGFB1—ulcerative colitis	5.13e-05	0.000298	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ADCY5—ulcerative colitis	4.81e-05	0.00028	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TNF—ulcerative colitis	4.79e-05	0.000279	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—PPARG—ulcerative colitis	4.61e-05	0.000268	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CHP1—ulcerative colitis	4.35e-05	0.000253	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—IL6—ulcerative colitis	3.87e-05	0.000225	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—DLD—ulcerative colitis	3.75e-05	0.000218	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PPARG—ulcerative colitis	3.59e-05	0.000209	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ALB—ulcerative colitis	3.23e-05	0.000188	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	3.01e-05	0.000175	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PTGS2—ulcerative colitis	2.82e-05	0.000164	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PTGS1—ulcerative colitis	2.75e-05	0.00016	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2.7e-05	0.000157	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CALM3—ulcerative colitis	2.48e-05	0.000144	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2.37e-05	0.000138	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ABCB1—ulcerative colitis	1.93e-05	0.000112	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PTGS1—ulcerative colitis	1.81e-05	0.000106	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ADCY5—ulcerative colitis	1.8e-05	0.000104	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CALM3—ulcerative colitis	1.63e-05	9.5e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PPARG—ulcerative colitis	1.34e-05	7.79e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ABCB1—ulcerative colitis	1.27e-05	7.39e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALB—ulcerative colitis	1.2e-05	7.01e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ADCY5—ulcerative colitis	1.18e-05	6.89e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PTGS2—ulcerative colitis	1.05e-05	6.13e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PPARG—ulcerative colitis	8.83e-06	5.14e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALB—ulcerative colitis	7.94e-06	4.62e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PTGS2—ulcerative colitis	6.95e-06	4.04e-05	CbGpPWpGaD
